Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates

Shire to Acquire NPS Pharma

Skadden is representing NPS Pharmaceuticals, Inc. in its $5.2 billion acquisition by Shire plc, announced January 11.

BACK TO TOP